Results 121 to 130 of about 161,137 (307)

The Course and Prognosis of Pemphigus: A Review of 42 Patients [PDF]

open access: yes, 2008
Pemphigus is a rare, chronic and life-threating autoimmune disease. The objective of this retrospective study was to evaluate the course and prognosis of pemphigus patients treated in our clinics. Medical records of 42 patients followed up regularly, and
Mehmet Harman, Sezer Çiçekli Turgutalp
core  

Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis [PDF]

open access: yes, 2009
The aim of this study was to evaluate the efficacy of a 0.05% clobetasol propionate ointment administered in trays to 22 patients with desquamative gingivitis in a double-blind, crossover, placebo-controlled trial.
AOKI, Valéria   +5 more
core   +1 more source

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris

open access: yesActa Dermato-Venereologica, 2020
Rituximab targets the B-lymphocyte antigen CD20, providing pemphigus vulgaris patients with long-term remissions. However, the effects of repeated courses have not yet been established.
Sharon Baum   +4 more
doaj   +1 more source

Validity of the EQ‐5D in patients with pemphigus vulgaris and pemphigus foliaceus

open access: yesBritish Journal of Dermatology, 2018
No studies to date have employed the EuroQoL EQ‐5D questionnaire to assess health‐related quality of life (HRQoL) in patients with pemphigus.
B. Tamási   +10 more
semanticscholar   +1 more source

Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris

open access: yesMediators of Inflammation, 2017
Pemphigus vulgaris (PV) is an autoimmune disease characterized by the presence of IgG autoantibodies against desmoglein-3. Despite the variety of findings, the chemokine and cytokine profiles that characterize the immune response in the disease are still
R. P. Timóteo   +7 more
semanticscholar   +1 more source

Setting the target for pemphigus vulgaris therapy.

open access: yesJCI Insight, 2017
Despite the rising incidence of autoimmunity, therapeutic options for patients with autoimmune disease still rely on decades-old immunosuppressive strategies that risk severe and potentially fatal complications.
C. Ellebrecht, A. Payne
semanticscholar   +1 more source

Rituximab therapy improves recalcitrant Pemphigus vulgaris [PDF]

open access: yes, 2015
Pemphigus is a severe life-threatening blistering disease associated with autoantibodies against cell adhesion proteins desmogleins 1 and 3. Patients with severe pemphigus commonly show high rates of relapse after conventional immunosuppressive therapy ...
Balighi, Kamran   +7 more
core  

Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris [PDF]

open access: yes, 2012
Pemphigus vulgaris (PV) is an autoimmune blistering skin disease characterized by suprabasal acantholysis and by autoantibodies against desmoglein 3 localized on desmosomes. In addition, caspases also seem to participate in this blistering disease. Focal
España, A. (Agustín)   +3 more
core   +1 more source

Novel Serum Oxidative Stress Biomarkers in Pemphigus Vulgaris: Clinical Insights and Implications for Pathogenesis

open access: yesDermatology Practical & Conceptual
Introduction: Pemphigus vulgaris is an autoimmune disorder characterized by blistering of the skin and mucous membranes due to the loss of cohesion between keratinocytes.
Naglaa El Sayed   +3 more
doaj   +1 more source

Oral Pemphigus Vulgaris in a Young Adult - Case Report [PDF]

open access: yes, 2003
Pemfigus vulgaris je rijetka, potencijalno smrtonosna kronična autoimuna vezikulobulozna bolest kože i sluznice. Zahvaća populaciju pedesetih i šezdesetih godina, a u edolescenciji je iznimno rijetka.
Ana Cekić-Arambašin, Danica Juras
core   +1 more source

Home - About - Disclaimer - Privacy